The OPPS was first implemented for services furnished on or after August 1, 2000
The strength of this study is that it is the first evaluation of OW semaglutide in a Korean population with T2D
Wong, PhD, MPH, a professor of medicine at the University of California, Irvine School of Medicine, and colleagues noted that the impact glucagon-like peptide 1 (GLP-1) receptor agonists have on weight loss have recently generated interest and investigation. Semaglutide activates GLP-1 receptors, improving incretin function and insulin secretion (glucose-dependent), inhibiting glucagon release and suppressing hepatic gluconeogenesis, resulting in reductions in both fasting as well as postprandial glucose, they wrote in Cardiovascular Drugs and Therapy
However, starting with a low dose and titrating slowly allows your gut to adapt
Novo Nordisk should enjoy their success while they can: semaglutide is likely to be eclipsed by newer, even better drugs that are just on the horizon
available as tablets and oral solution
